Antiplatelet pretreatment in coronary disease

State-of-the-Art

Apr 13
Antiplatelet pretreatment in coronary disease
Gurleen Kaur, Deepak L. Bhatt, et al.
This review summarizes the current evidence on the role of pretreatment with antiplatelet agents, including aspirin and P2Y12 inhibitors, in the management of patients with coronary artery disease undergoing percutaneous revascularization.
free

Editorial

Apr 10
Rethinking post-PCI risk stratification
Christiaan J.M. Vrints
The study discusses the management of chronic coronary syndromes, highlighting the need for a more personalized approach to PCI, with the use of intravascular imaging and tailored pharmacotherapy to improve long-term outcomes.
free

Original Research

Apr 9
Prognostic impact of HIR criteria in PCI
Valeria Raona, Roxana Mehran, et al.
This study evaluated the prevalence and prognostic impact of guideline-defined high ischaemic risk criteria in a large cohort of chronic coronary syndrome patients undergoing percutaneous coronary intervention. The majority of patients met at least one high-risk criterion, which was associated with increased risk of adverse cardiovascular events.
Prognostic impact of HIR criteria in PCI

New issue

Apr 6
A new issue of EuroIntervention

This issue of EuroIntervention includes a State-of-the-Art on antiplatelet pretreatment in coronary disease; Original Research on the prognostic impact of the high ischaemic risk criteria in PCI; a Meta-Analysis of the prognostic impact of complex PCI; and a Flashlight on an updated coronary thrombectomy technique.

A new issue of EuroIntervention

Podcast

Apr 2
Editor's Choice: a new EIJ podcast

Editor's Choice is EuroIntervention's latest podcast series, bringing you key highlights of selected recently published studies. Listen in twice monthly as the authors themselves discuss their work with host Aaysha Cader. Episode 1 with Tobias Geisler and Mia Ravn Jacobsen is out now - with more episodes to come!

Editor's Choice: a new EIJ podcast

Flashlight

Apr 1
3D ICE-guided TTVR
Srivatsan Swaminathan, Gilbert H.L. Tang, et al.
A 73-year-old female with a history of rheumatic fever and severe mitral stenosis who had undergone TMVR presented with severe tricuspid regurgitation. 3D ICE-guided TTVR was performed, with a successful outcome.
3D ICE-guided TTVR

CONSENSUS DOCUMENT

Mar 31
DAPT for secondary prevention in patients with ACS

This consensus provides practical guidance on personalizing dual antiplatelet therapy in patients with acute coronary syndrome undergoing percutaneous coronary intervention to optimize clinical outcomes by balancing ischemic and bleeding risks.

DAPT for secondary prevention in patients with ACS
open access
Editor's Choice Podcast Listen now


Updated coronary thrombectomy technique

Flashlight

Apr 8
Updated coronary thrombectomy technique
Quentin Liabot, Juan F. Iglesias, et al.
This case report describes a novel approach to mechanical coronary thrombectomy, combining a stent retriever with continuous aspiration using the CAT RX system, which the authors suggest may enhance efficacy compared to aspiration alone.
open access

Receive our newsletter
Subscribe banner

Trial Design

Mar 30
mViV vs rMVR for BVD: the SURVIV trial
Dimytri A. Siqueira, Fausto Feres, et al.
The SURVIV trial is a randomized study comparing transcatheter mitral valve-in-valve and surgical redo-mitral valve replacement in patients with failed bioprosthetic mitral valves.
mViV vs rMVR for BVD: the SURVIV trial

Research Correspondence

Mar 27
Extended-length introducer sheaths for TAVI
Yusuke Kobari, Ole De Backer, et al.
The study found that the use of an extended-length sheath during transfemoral transcatheter aortic valve implantation (TF-TAVI) in patients with a hostile aortic anatomy is feasible and may enhance procedural safety by potentially avoiding vascular and/or calcific/thromboembolic complications.
Extended-length introducer sheaths for TAVI

Editorial

Mar 25
An aortic valve FFR?
Morton J. Kern, Derek Antoku

The editorial discusses the potential use of transvalvular hemodynamics, such as the stress aortic valve index (SAVI), to help guide decision-making around the need for aortic valve replacement in patients with moderate or mild aortic stenosis.

free

Original Research

Mar 23
The SAVI-AoS trial
Rob Eerdekens, Pim A.L. Tonino, et al.
This study evaluated symptomatic patients with moderate aortic stenosis and preserved ejection fraction using invasive and non-invasive assessments at rest and during stress. The stress aortic valve index strongly predicted the need for aortic valve intervention.
The SAVI-AoS trial

Flashlight

Mar 20
Leaflet avulsion after UNICORN
Arif A. Khokhar, Ole De Backer, et al.
The content discusses the UNICORN technique for reducing the risk of coronary obstruction during redo-TAVI, highlighting the need for caution due to the unpredictable nature of complete leaflet avulsion and the potential benefits of orthotopic coronary wiring and stenting.
Leaflet avulsion after UNICORN

State-of-the-Art

Mar 18
TAVI thrombosis
Mia Ravn Jacobsen, Tobias Geisler, et al.
This review examines the prevalence, mechanisms, and management of leaflet thrombosis after transcatheter aortic valve implantation (TAVI), a minimally invasive procedure for severe aortic stenosis.
TAVI thrombosis
free

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved